Grifols (GIFLF) Free Cash Flow (2010 - 2022)
Grifols' (GIFLF) quarterly Free Cash Flow came in at -$1.5 million in Q4 2022, down 101.25% quarter-over-quarter from $116.3 million in Q1 2020.
Analysis
Grifols (GIFLF) Free Cash Flow (2010 - 2022) Analysis & Trends
Grifols (GIFLF) has reported Free Cash Flow for 12 consecutive years, with -$1.5 million the latest figure, recorded in Q4 2022.
- For the quarter ending Q4 2022, Free Cash Flow changed N/A year-over-year to -$1.5 million; the trailing twelve-month figure through Dec 2022 stood at $299.7 million (changed N/A YoY), and the FY2025 full-year result was $883.5 million, up 23.59% from the prior year.
- Free Cash Flow fell to -$1.5 million in Q4 2022 per GIFLF's latest filing, from $116.3 million in the prior quarter.
- Across five years, Free Cash Flow topped out at $466.5 million in Q4 2018 and bottomed at -$190.6 million in Q1 2019.
- Historically, Free Cash Flow has averaged $152.4 million across 4 years, with a median of $116.3 million in 2020.
- The sharpest annual moves came in 2019 and 2020: Free Cash Flow sank 267.38% in 2019, then soared 161.02% in 2020.
- Over 4 years, Free Cash Flow stood at $466.5 million in 2018, then dropped by 19.52% to $375.5 million in 2019, then sank by 69.02% to $116.3 million in 2020, then plunged by 101.25% to -$1.5 million in 2022.
- According to Business Quant data, Free Cash Flow over the past three periods registered -$1.5 million, $116.3 million, and $375.5 million for Q4 2022, Q1 2020, and Q4 2019 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 203.97 Bn | 189.99 Bn | 7.24 Bn | 3.49 Bn |
| 2 | Gilead Sciences | 178.74 Bn | 175.56 Bn | 6.22 Bn | 3.43 Bn |
| 3 | Vertex Pharmaceuticals | 130.73 Bn | 122.88 Bn | 2.84 Bn | 1.01 Bn |
| 4 | Regeneron Pharmaceuticals | 80.42 Bn | 72.42 Bn | 3.93 Bn | 572.80 Mn |
| 5 | Argenx Se | 60.40 Bn | 55.21 Bn | 1.37 Bn | - |
| 6 | Moderna | 57.65 Bn | 52.52 Bn | 52.00 Mn | -563.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.37 Bn | 30.07 Bn | 992.69 Mn | 292.04 Mn |
| 8 | Biogen | 32.15 Bn | 30.86 Bn | 1.96 Bn | 408.00 Mn |
| 9 | Roivant Sciences | 29.58 Bn | 29.58 Bn | 1.16 Mn | -268.64 Mn |
| 10 | Grifols | 7.54 Bn | 9.09 Bn | 3.33 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2022 | -1.46 Mn |
| Mar 31, 2020 | 116.32 Mn |
| Dec 31, 2019 | 375.47 Mn |
| Mar 31, 2019 | -190.63 Mn |
| Dec 31, 2018 | 466.54 Mn |
| Jun 30, 2018 | 186.75 Mn |
| Mar 31, 2018 | 113.89 Mn |
| Dec 31, 2017 | 671.81 Mn |
| Jun 30, 2017 | 256.39 Mn |
| Mar 31, 2017 | 154.89 Mn |
| Dec 31, 2016 | 194.78 Mn |
| Sep 30, 2016 | 229.95 Mn |
| Dec 31, 2015 | 340.22 Mn |
| Sep 30, 2015 | 194.93 Mn |
| Jun 30, 2015 | 246.47 Mn |
| Mar 31, 2015 | 38.56 Mn |
| Dec 31, 2014 | 403.75 Mn |
| Sep 30, 2014 | 870.02 Mn |
| Jun 30, 2014 | -170.75 Mn |
| Mar 31, 2014 | 171.11 Mn |